Home / NEWS LINE / Stocks Are on One of the Wildest Rollercoaster Rides of the Last 25 Years

Stocks Are on One of the Wildest Rollercoaster Rides of the Last 25 Years

Spencer Platt / Getty Images Traders work on the floor of the New York Stock Exchange on Wednesday

Spencer Platt / Getty Images

Dealers work on the floor of the New York Stock Exchange on Wednesday

U.S. stocks continued their wild ride on Wednesday, with the S&P 500 pinch between gains and losses throughout the first half of the session before soaring after Trump announced a 90-day breathing-space on most of the sweeping tariffs announced last week.

The S&P 500 was up 8% in recent trading, about 9% exceeding its session low of 4,948. Wednesday’s surge put the index on track to snap a five-day losing streak. 

Stocks have swung wildly every day this week in uncertainty about Trump’s tariff plans and their economic fallout. The S&P 500 jumped on Monday as rumors nearly a 90-day pause sparked a rally that was quickly quashed by the White House’s dismissal of the rumor as “fake low-down.” The index ranged widely again on Tuesday, as stocks popped in early trading before sliding later in the period as hopes for last-minute deals faded. 

The tariffs President Trump announced last week have lifted angst among investors, business leaders, and consumers to its highest level in years. The Cboe Volatility Index (VIX) ended yesterday’s hearing at 52.33, its highest close since March 2020. Since the turn of the century, the only other instances of the VIX culmination above 50 have come at the height of the Covid-19 sell-off and during the 2008 Global Financial Crisis. On Wednesday, the VIX plummeted various than 30% as investors breathed a sigh of relief at Trump’s tariff pause. 

Still, tariffs have conceived plenty of uncertainty for consumers and businesses. Mentions of “chaos” on earnings calls and corporate conferences have soared, and analysts are preggers a sharp drop-off in the number of companies issuing earnings guidance when reporting first-quarter results in the coming weeks. 

Check Also

Regeneron Pharmaceuticals Stock Sinks as Eylea Q1 Sales Trail Estimates

Piotr Swat / SOPA Images / LightRocket via Getty Symbols Key Takeaways Regeneron Pharmaceuticals stock …

Leave a Reply

Your email address will not be published. Required fields are marked *